GEM-104(Gemini Therapeutics)

N/A

Report date: 2024/11/07 16:30:24

Base Information

Drug NameGEM-104(Gemini Therapeutics)
Drug Alias NameGEM-104
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionComplement Factor I modulators
TargetsComplement Factor I
Therapy Area/IndicationsMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGemini Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesGemini Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMacular Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A